Skip to main content

COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer

Publication ,  Conference
Agarwal, D; Conejo-Garcia, JR; Scholler, J; Tchou, JC
Published in: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
2020

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

EISSN

1879-1190

ISSN

1072-7515

Publication Date

2020

Volume

231

Issue

4

Start / End Page

S34 / S35

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Agarwal, D., Conejo-Garcia, J. R., Scholler, J., & Tchou, J. C. (2020). COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (Vol. 231, pp. S34–S35).
Agarwal, Divyansh, Jose Ramon Conejo-Garcia, John Scholler, and Julia C. Tchou. “COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer.” In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 231:S34–35, 2020.
Agarwal D, Conejo-Garcia JR, Scholler J, Tchou JC. COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. In: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2020. p. S34–5.
Agarwal, Divyansh, et al. “COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer.” JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, vol. 231, no. 4, 2020, pp. S34–35.
Agarwal D, Conejo-Garcia JR, Scholler J, Tchou JC. COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2020. p. S34–S35.

Published In

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

EISSN

1879-1190

ISSN

1072-7515

Publication Date

2020

Volume

231

Issue

4

Start / End Page

S34 / S35

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 1103 Clinical Sciences